Health officials are investigating a recent increase in cases of Crimean-Congo Hemorrhagic Fever (CCHF),a potentially deadly viral disease also known as “Behemoth” disease,across several Indonesian provinces.Reported cases have risen sharply since early May 2024, with East Nusa Tenggara province notably affected [[1]]. CCHF, endemic in over 30 countries, is typically spread by ticks and can cause severe illness requiring immediate medical attention.
Rising Cases of ‘Behemoth’ Disease: What You Need to Know
A resurgence of the “Behemoth” disease, officially known as Crimean-Congo Hemorrhagic Fever (CCHF), is prompting health officials to raise awareness and reinforce preventative measures. The recent increase in cases, particularly in several regions, underscores the ongoing threat posed by this viral illness.
According to reports, as of May 16, 2024, a total of 40 confirmed cases of CCHF have been identified across various provinces. The majority of these cases – 26 – were reported in the province of East Nusa Tenggara. Other affected areas include West Nusa Tenggara with 8 cases, Central Java with 3 cases, and one case each in South Sulawesi, East Java, and Papua.
“Behemoth” disease is transmitted to humans through contact with infected ticks, animals (such as cattle, sheep, and goats), or through direct contact with infected human blood or tissues. Symptoms typically appear within five to six days after infection and can include fever, muscle aches, dizziness, and internal bleeding.
Health authorities are emphasizing the importance of preventative measures, including avoiding tick bites by using protective clothing and repellents, practicing proper hygiene when handling animals, and avoiding close contact with individuals exhibiting symptoms of the disease. Early diagnosis and supportive care are crucial for managing CCHF, as there is currently no specific antiviral treatment available.
The recent spike in cases is prompting increased surveillance and public health education campaigns to mitigate further spread. The findings highlight the continued need for vigilance and proactive measures to control this potentially life-threatening disease.
The disease has a fatality rate ranging from 20% to 40%, according to the World Health Organization.
